Alternatively, or in complement, it is possible that mutated signaling processes modulate immune infiltration in the tumor microenvironment, supported by the selection of mutations in multiple signaling genes such as beta-catenin and protein kinase and phosphatase genes (Figs. 1B and 2C). The gene discussed is WEE1; the disease is neoplasm.